Skip to main content
. 2019 Aug 2;46:66–78. doi: 10.1016/j.ebiom.2019.07.050

Fig. 10.

Fig. 10

Molecular mechanism of miR-134 involvement in ESCC tumorigenesis. miR-134 targets PLXNA1 to block the MAPK signalling pathway, thus inhibiting ESCC cell proliferation and LNM while promoting tumour cell apoptosis.